Call for tenders Supplies
Raamovereenkomst voor het leveren van antibiotica
Notice published in Dutch. The AI analysis summarises it for you in your language.
Tenders due closed — 26 May 2026 at 16:00
- Public buyer
- Hospilim VZW
Diepenbeek - Place of performance
- 3590 Diepenbeek, Limburg
not published: buyer's address - Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 13 May 2026
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Het voorwerp van de opdracht is het leveren van antibiotica
57 lots
- 2026-HospiLim-1002 - 1
- 2026-HospiLim-1002 - 2
- 2026-HospiLim-1002 - 3
- 2026-HospiLim-1002 - 4
- 2026-HospiLim-1002 - 5
- 2026-HospiLim-1002 - 6
- 2026-HospiLim-1002 - 7
- 2026-HospiLim-1002 - 8
- 2026-HospiLim-1002 - 9
- 2026-HospiLim-1002 - 10
- 2026-HospiLim-1002 - 11
- 2026-HospiLim-1002 - 12
- 2026-HospiLim-1002 - 13
- 2026-HospiLim-1002 - 14
- 2026-HospiLim-1002 - 15
- 2026-HospiLim-1002 - 16
- 2026-HospiLim-1002 - 17
- 2026-HospiLim-1002 - 18
- 2026-HospiLim-1002 - 19
- 2026-HospiLim-1002 - 20
- 2026-HospiLim-1002 - 21
- 2026-HospiLim-1002 - 22
- 2026-HospiLim-1002 - 23
- 2026-HospiLim-1002 - 24
- 2026-HospiLim-1002 - 25
- 2026-HospiLim-1002 - 26
- 2026-HospiLim-1002 - 27
- 2026-HospiLim-1002 - 28
- 2026-HospiLim-1002 - 29
- 2026-HospiLim-1002 - 30
- 2026-HospiLim-1002 - 31
- 2026-HospiLim-1002 - 32
- 2026-HospiLim-1002 - 33
- 2026-HospiLim-1002 - 34
- 2026-HospiLim-1002 - 35
- 2026-HospiLim-1002 - 36
- 2026-HospiLim-1002 - 37
- 2026-HospiLim-1002 - 38
- 2026-HospiLim-1002 - 39
- 2026-HospiLim-1002 - 40
- 2026-HospiLim-1002 - 41
- 2026-HospiLim-1002 - 42
- 2026-HospiLim-1002 - 43
- 2026-HospiLim-1002 - 44
- 2026-HospiLim-1002 - 45
- 2026-HospiLim-1002 - 46
- 2026-HospiLim-1002 - 47
- 2026-HospiLim-1002 - 48
- 2026-HospiLim-1002 - 49
- 2026-HospiLim-1002 - 50
- 2026-HospiLim-1002 - 51
- 2026-HospiLim-1002 - 52
- 2026-HospiLim-1002 - 53
- 2026-HospiLim-1002 - 54
- 2026-HospiLim-1002 - 55
- 2026-HospiLim-1002 - 56
- 2026-HospiLim-1002 - 57
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33651000 33600000 33651100 33690000
Winning prices for comparable contracts
- A quarter below
- €290,000
- Median
- €403,000
- A quarter above
- €1,351,075
Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Likely competitors: who wins with this buyer in this field
- Duomed Belgium NV · 8 contracts won
- Fresenius Kabi NV · 6 contracts won
- Accord Healthcare BV · 4 contracts won
- Viatris bv · 4 contracts won
- EG · 4 contracts won
Partners and subcontractors
Contract too big or too broad for you alone? Bid as a temporary consortium, or offer your services as a subcontractor.
Create your free account to see who is looking for a partner on this contract, and to register.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Immunoglobuline humaine normale pour administration intraveineuse Cliniques universitaires Saint Luc · 22 October 2026 |
CSL BEHRING | €16,277,080 |
| Antimycotica AZ Delta vzw · 21 October 2026 |
Arega Pharma NV Sandoz NV Fresenius Kabi NV Pfizer NV |
€300,945 |
| Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease European Commission, DG SANTE - Health and Food Safety · 1 October 2026 |
Huvepharma EOOD | €2,385,950 |
| Raamovereenkomst voor het leveren van immunoglobulines IV 10% Universitair Ziekenhuis Gent · 24 September 2026 |
CSL BEHRING NV | €27,360,000 |
| Aankoop en levering van plasmaderivaten Algemeen Ziekenhuis Sint-Maria vzw · 15 September 2026 |
CSL BEHRING DEPARTEMENT CENTRAL DE FRACTIONNEMENT Prothya Biosolutions Netherlands B.V. OCTAPHARMA BENELUX |
€18,749,295 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 329450-2026.